Insider · CIK 0001555132
Catherine A. Sohn
Files at ALT (Altimmune, Inc.), MAZE (Maze Therapeutics, Inc.). First filing Mar 18, 2025, latest Jan 5, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ALT: Altimmune, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | Altimmune, Inc. | $2,118 500 shares | +50% | +21% from low-47% from high | |
| 31Weak | Altimmune, Inc. | $5,785 1,000 shares | - | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | ALT Altimmune, Inc. | POpen-market purchase Common Stock, par value $0.0001 | +500 | $4.24 | $2,118 | 1,500 | Jan 5, 2026 |
| Sep 25, 2025 | ALT Altimmune, Inc. | AGrant or award Stock Options (option to buy)derivative | +48,800 | $0.00 | $0 | 48,800 | Sep 29, 2025 |
| Sep 22, 2025 | MAZE Maze Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +18,000 | $0.00 | $0 | 18,000 | Sep 24, 2025 |
| Mar 17, 2025 | ALT Altimmune, Inc. | POpen-market purchase Common Stock, par value $0.0001 | +1,000 | $5.78 | $5,785 | 1,000 | Mar 18, 2025 |
| Feb 6, 2025 | ALT Altimmune, Inc. | AGrant or award Stock Options (option to buy)derivative | +18,600 | $0.00 | $0 | 18,600 | Feb 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.